Abstract
Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with various clinical and serological manifestations. Previous studies have shown the association of SLE and anti-Ro antibody with a series of clinical manifestations. We investigated this association in Brazilian patients with SLE. Five hundred and nine consecutive patients who fulfilled the revised American College of Rheumatology criteria for the SLE were enrolled in the study from June to December 2007. All patients were from our Service of Rheumatology, School of Medicine, University of São Paulo, Brazil. Frequencies of a series of laboratorial and clinical manifestations were calculated. Anti-Ro antibody was associated to anti-La antibody, female, and cutaneous vasculitis. In multivariate analysis, patients with anti-Ro antibody has 1.63 (95% CI 1.07–2.50) more risk to develop cutaneous vasculitis than patients without this antibody. Our data have demonstrated that anti-Ro antibody is an independent useful serologic marker for cutaneous vasculitis.
Similar content being viewed by others
References
Sibilia J (1998) Ro (SS-A) and anti-Ro (SS-A): an update. Rev Rhum Engl Ed 65:45–57
Harley JB, Scofield RH, Reichlin M (1992) Anti-Ro in Sjögren’s syndrome and systemic lupus erythematosus. Rheum Dis Clin North Am 18:337–358
Penner E, Reichlin M (1982) Primary biliary cirrhosis associated with Sjögren’s syndrome: evidence for circulating and tissue-deposited Ro/anti-Ro immune complexes. Arthritis Rheum 25:1250–1253
Cavazzana I, Franceschini F, Quinzanini M, Manera C, Del Papa N, Maglione W, Comina D, Radice A, Sinico RA, Cattaneo R (2006) Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. Clin Exp Rheumatol 24:59–64
Wolin SL, Reinisch KM (2006) The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments or structure. Autoimmun Rev 5:367–372
Provost TT, Levin LS, Watson RM, Mayo M, Ratrie H 3rd (1991) Detection of anti Ro(SSA) antibodies by gel double diffusion and a sandwich ELISA in systemic and subacute cutaneous lupus erythematosus and Sjogren’s syndrome. J Autoimmun 4:87–96
Clark G, Reichlin M, Tomasi TB (1969) Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 102:117–122
Maddison PJ, Mogavero M, Provost TT, Reichlin M (1976) The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 6:189–195
Synkowski DR, Reichlin M, Provost TT (1982) Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features. J Rheumatol 9:380–385
Hochberg MC, Boyd RE, Aheran JM, Arnett FC, Bias WB, Provost TT, Stevens MB (1985) Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markerjs in 150 patients with emphasis on demographic subsets. Medicine 64:285–295
Mond CB, Peterson MG, Rothfield NF (1989) Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 32:202–204
Sutej PG, Gear AJ, Morrison RC, Tikly M, de Beer M, Dos Santos L, Sher R (1989) Photosensitivity and anti-Ro (SS-A) antibodies in black patients with systemic lupus erythematosus (SLE). Br J Rheumatol 28:321–324
Kurien BT, Newland J, Paczkowski C, Moore KL, Scofield RH (2000) Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol 120:209–217
Vilá LM, Molina MJ, Mayor AM, Peredo RA, Santaella ML, Vilá S (2006) Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus. Lupus 15:892–898
Costedoat-Chalumeau N, Georgin-Lavialle S, Amoura Z, Piette JC (2005) Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus 14:660–664
Clancy RM, Neufing PJ, Zheng P, O’Mahony M, Nimmerjahn F, Gordon TP, Buyon JP (2006) Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and –SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 116:2413–2422
La zzerini PE, Capecchi PL, Guideri F, Acampa M, Galeazzi M, Laghi-Pasini F (2006) Connective tissue diseases and cardiac rhythm disorders: an overview. Autoimmun Rev 5:306–313
Shahin AA, Shahin HA, Hamid MA, Amin MA (2004) Cardiac involvement in patients with systemic lupus erythematosus and correlation of valvular lesions with anti-Ro/SS-A and anti-La/SS-B antibody levels. Mod Rheumatol 14:117–122
Oshiro AC, Derbes SJ, Stopa AR, Gedalia A (1997) Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis 56:i272–i274
Alexander EL, Arnett FC, Provost TT, Stevens MB (1983) Sjögren’s syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 98:155–159
Moutsopoulos HM, Zerva LV (1990) Anti-Ro (SSA)/La (SSB) antibodies and Sjögren’s syndrome. Clin Rheumatol 9(1 Suppl 1):123–130
Alexander EL, Provost TT (1983) Cutaneous manifestations of primary Sjögren’s syndrome: a refletion of vasculitis and association with anti-Ro (SSA) antibodies. J Invest Dermatol 80:386–391
Alexander EL, Provost TT (1987) Sjögren’s syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch Dermatol 123:801–810
Alexander EL, Hirsch TJ, Arnett FC, Provost TT, Stevens MB (1982) Ro (SSA) and La (SSB) antibodies in the clinical spectrum of Sjögren’s syndrome. J Rheumatol 9:239–246
Cho CS, Park SH, Min JK, Lee SH, Kim HY (1997) Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjögren’s syndrome. Korean J Intern Med 12:176–181
Boire G, Ménard HA (1988) Clinical significance of anti-Ro (SSA) antibody in rheumatoid arthritis. J Rheumatol 15:391–394
Magro CM, Crowson AN (2003) The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 30:1–10
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
McCauliffe DP (1997) Cutaneous diseases in adults associated with Anti-Ro/SS-A autoantibody production. Lupus 6:158–166
Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190:104–111
Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33:291–437
Yell JA, Mbuagbaw J, Burge SM (1996) Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 135:355–362
Grigor R, Edmonds J, Lewkonia R, Bresnihan B, Hughes GR (1978) Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 37:121–128
Bouaziz JD, Barete S, Le Pelletier F, Amoura Z, Piette JC, Francès C (2007) Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases. Lupus 16:163–167
Watson R (1989) Cutaneous lesions in systemic lupus erythematosus. Med Clin North Am 73:1091–1111
Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D (1997) Vasculitis in systemic lupus erythematosus. Lupus 6:235–242
Provost TT, Watson R, Simmons-O’Brien E (1996) Anti-Ro (SS-A) antibody positive Sjögren’s/lupus erythematosus overlap syndrome. Lupus 6:105–111
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukuda, M.V., Lo, S.C., de Almeida, C.S. et al. Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus. Clin Rheumatol 28, 301–304 (2009). https://doi.org/10.1007/s10067-008-1043-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-008-1043-5